Graviton Bioscience
Heeyoung P. is an experienced professional in the regulatory affairs field. With a wealth of experience working in various pharmaceutical and healthcare companies, Heeyoung currently holds the title of Vice President, Regulatory at Graviton Bioscience. Prior to this role, Heeyoung has worked in positions such as Head and Senior Director of Regulatory and Quality at Aptinyx Inc., Director of Regulatory Affairs at LEO Pharma, and Director of Regulatory Affairs at Mitsubishi Tanabe Pharma America. With a Master of Science in Bioscience Regulatory Affairs from The Johns Hopkins University, Heeyoung has a strong educational background to complement their extensive work experience in the industry.
Graviton Bioscience
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.